Alzheimer Europe launches new report on dementia, recommends future priorities across Europe

NewsGuard 100/100 Score

At an online European Parliament workshop hosted by Sirpa Pietikäinen, MEP (Finland), Alzheimer Europe launched a new report "Dementia as a European Priority - A Policy Overview" which takes stock of dementia policy at an EU level and sets out recommendations for future priorities across Europe.

As the European Union is about to agree a new long-term budget and the details of the EU4Health and Horizon Europe programmes are being finalised, Alzheimer Europe reflects on the place of dementia as a political priority in Europe in recent years.

This includes the different ways in which dementia policy and research have been supported by the three institutions of the EU, as well as some of the high-profile coordination and research projects which have been made possible as a result of EU funding.

In the report, Alzheimer Europe also highlights some of its key activities in campaigning for change, as well as the work it has coordinated and participated in, along with its national member associations, to raise the profile of the condition and build an evidence base to make the case for the prioritisation of dementia.

Despite the progress made and the knowledge generated, the report highlights that people living with dementia continue to face a number of challenges. These challenges, which concern wider society too, include the increase in the number of people living with dementia (estimated to double by 2050) and the societal and economic cost of dementia.

As a result, the report sets out a number of recommendations for the EU, outlining specific areas in which dementia should be prioritised across international, health, research and social policy.

Recommendations include:

  • Prioritizing dementia research in EU Research Programmes (including Horizon Europe), providing a fair allocation of resources and funding for existing programmes and better coordination between programmes
  • Prioritizing dementia within policies relating to chronic diseases, mental health and ageing, both at an EU and national level
  • Supporting the Member States to work towards the implementation of the World Health Organization's Global Action Plan on Dementia 2017-2025
  • Recognizing dementia as a disability and including dementia in disability policies.

Commenting on the publication of the report, Alzheimer Europe's Executive Director, Jean Georges, stated:

"Alzheimer Europe has worked with its members over the past three decades to ensure that dementia is a political priority at the European level. The policy landscape has changed dramatically during this time and we have seen considerable progress as both national governments and the EU have given dementia greater prominence within their health and research policies."

However, there is much still to do. The European Union and its Member States are on the cusp of historic deals on the EU budget, a greatly expanded Health Programme and the forthcoming Horizon Europe research programme. If we are to build on the knowledge, experience and progress gained in recent years, it is vital that dementia remain a political priority at a European level across health, research and social policy."

Jean Georges, Executive Director, Alzheimer Europe

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antipsychotics for dementia associated with elevated risks of serious adverse outcomes